Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Julius

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Klinische Wochenschrift|December 1, 1987
Loss of fat, water, and protein during very low calorie diets and complete starvationM Weck, S Fischer, M Hanefeld, et al.
Acta Diabetologica|October 3, 2002
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat massS Fischer, M Hanefeld, S M Haffner, et al.
Diabetologia|December 1, 1996
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upM Hanefeld, S Fischer, U Julius, et al.
European Journal of Clinical Investigation|January 20, 1999
DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical resultsL J Dräger, U Julius, K Kraenzle, et al.
Der Internist|April 28, 2016
[Therapeutic algorithm for lipoprotein apheresis and PCSK9 inhibition for severe hypercholesterolemia or isolated lipoprotein(a) hyperlipoproteinemia]V J J Schettler, J Ringel, S Jacob, et al.
Atherosclerosis. Supplements|November 4, 2017
Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?V J J Schettler, J Ringel, S Jacob, et al.
Journal of Lipid Research|October 1, 1996
Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approachJ Pietzsch, B Wiedemann, U Julius, et al.
Atherosclerosis. Supplements|February 5, 2010
Nitric oxide and endothelin after lipid apheresis - a pilot studyJ Beyer-Westendorf, W Seitz, N Jabs, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 16, 2008
Heparin-induced Extracorporal LDL precipitation (H.E.L.P) in diabetic foot syndrome - preventive and regenerative potential?H Rietzsch, I Panzner, T Selisko, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 22, 1999
Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemiaS Gehrisch, H Kostka, M Tiebel, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Klinische Wochenschrift|December 1, 1987
Loss of fat, water, and protein during very low calorie diets and complete starvationM Weck, S Fischer, M Hanefeld, et al.
Acta Diabetologica|October 3, 2002
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat massS Fischer, M Hanefeld, S M Haffner, et al.
Diabetologia|December 1, 1996
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upM Hanefeld, S Fischer, U Julius, et al.
European Journal of Clinical Investigation|January 20, 1999
DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical resultsL J Dräger, U Julius, K Kraenzle, et al.
Der Internist|April 28, 2016
[Therapeutic algorithm for lipoprotein apheresis and PCSK9 inhibition for severe hypercholesterolemia or isolated lipoprotein(a) hyperlipoproteinemia]V J J Schettler, J Ringel, S Jacob, et al.
Atherosclerosis. Supplements|November 4, 2017
Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?V J J Schettler, J Ringel, S Jacob, et al.
Journal of Lipid Research|October 1, 1996
Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approachJ Pietzsch, B Wiedemann, U Julius, et al.
Atherosclerosis. Supplements|February 5, 2010
Nitric oxide and endothelin after lipid apheresis - a pilot studyJ Beyer-Westendorf, W Seitz, N Jabs, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 16, 2008
Heparin-induced Extracorporal LDL precipitation (H.E.L.P) in diabetic foot syndrome - preventive and regenerative potential?H Rietzsch, I Panzner, T Selisko, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 22, 1999
Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemiaS Gehrisch, H Kostka, M Tiebel, et al.
Pageof 12